CELGENE, SOCIEDADE UNIPESSOAL LDA
NIF 507791690
Risk Flags
A1 · Repeat Direct Award
€74,910,184
73 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH
€74,910,184
73 contracts
A2 · Late Publication
€1,762,137,441
1,447 contracts
Contract published to BASE more than 10 days after the signing date
LOW
€1,762,137,441
1,447 contracts
A5 · Threshold Splitting
€9,472,569
62 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH
€9,472,569
62 contracts
A6 · Low Competition
€58,172
2 contracts
Only one bidder participated in a competitive procedure
MEDIUM
€58,172
2 contracts
Procurement Network
Aggregated links between this entity and connected counterparties
Public view excludes person-level links and tax identifiers.
Loading network…
No connections found for the current filters.
Legend
Focus entity
Public body
Company
Anonymized individual
Contracts by Contracting Authority
Page 1 of 3 · 42 authorities
All Contracts Won
Signal:
All
A1 · Repeat Direct Award
A2 · Late Publication
A5 · Threshold Splitting
A6 · Low Competition
A9 · Abnormal Price Reduction
C3 · Missing Mandatory Fields
Page 1 of 29 · 1,447 contracts
Ozanimod 0.92 mg cáps
PT · 10818414
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Universit...
NIF 508080142
€0
2024-02-17
€0
2024-02-17
VÁRIOS MEDICAMENTOS
PT · 10588227
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar de Setúba...
NIF 507606787
€25,885
2024-02-09
€25,885
2024-02-09
UI/615/2024 - POMALIDOMIDA
PT · 10881539
· Ajuste Direto Regime G...
A2 · Late Publication
Instituto Português de Onco...
NIF 506361616
€218,988
2024-02-02
€218,988
2024-02-02
060100232024 - C/ BASE NO CPA 2021_06
PT · 10588081
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar e Univers...
NIF 510103448
€101,087
2024-01-31
€101,087
2024-01-31
91/1330/2024 - PACLItaxel em nanoparticulas 100 mg Pó disp inj Fr IV
PT · 10683534
· Ajuste Direto Regime G...
A2 · Late Publication
Centro Hospitalar Universit...
NIF 510745997
€18,000
2024-01-25
€18,000
2024-01-25
Aquisição de PACLItaxel 5 mg/ml Pó susp inj Fr IV (Nab)
PT · 10540406
· Ajuste Direto Regime G...
A2 · Late Publication
Unidade Local de Saúde do A...
NIF 508786193
€0
2024-01-22
€0
2024-01-22
VÁRIOS MEDICAMENTOS
PT · 10539835
· Ajuste Direto Regime G...
A1 · Repeat Direct Award
A2 · Late Publication
Centro Hospitalar de Setúba...
NIF 507606787
€9,091
2024-01-22
€9,091
2024-01-22
VÁRIOS MEDICAMENTOS
PT · e445c7ce85f00d5a70a3
· Ajuste Direto Regime G...
A2 · Late Publication
Centro Hospitalar de Setúba...
NIF 507606787
€9,091
2024-01-22
€9,091
2024-01-22
VÁRIOS MEDICAMENTOS
PT · 10532147
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar de Setúba...
NIF 507606787
€130,873
2024-01-19
€130,873
2024-01-19
Pomalidomida 4 mg Cáps
PT · 10778557
· Ajuste Direto Regime G...
A2 · Late Publication
Instituto Português de Onco...
NIF 506362299
€14,827
2024-01-15
€14,827
2024-01-15
PACLItaxel 5 mg/ml Pó disp inj Fr IV (Nab-Paclitaxel)
PT · 10778470
· Ajuste Direto Regime G...
A2 · Late Publication
Instituto Português de Onco...
NIF 506362299
€2,160
2024-01-15
€2,160
2024-01-15
AD 118/2023 Aquisição Medicamento Ozanimod 0,92 mg Caps (CP 2022/173)
PT · 10555121
· Ao abrigo de acordo-qu...
A2 · Late Publication
A6 · Low Competition
Centro Hospitalar Universit...
NIF 506361659
€27,432
2024-01-15
€27,432
2024-01-15
Aquisição de Medicamentos Diversos ao abrigo do Acordo Quadro 2022/173 para o ano 2024
PT · 10726846
· Ao abrigo de acordo-qu...
A2 · Late Publication
Unidade Local de Saúde de B...
NIF 515545180
€314,414
2024-01-11
€314,414
2024-01-11
Medicamentos diversos ao abrigo do CPA 2022/173 dos SPMS, para o ano 2024
PT · 10774671
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Unidade Local de Saúde de S...
NIF 517392259
€255,847
2024-01-10
€255,847
2024-01-10
4180013/2024 - MEDICAMENTOS DO FORO ONCOLÓGICO
PT · 10704786
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Barreiro ...
NIF 509186998
€0
2024-01-02
€0
2024-01-02
Aquisição de LANREOTIDA [120 MG/488 MG; SERINGA], OZANIMOD [0.92 MG; CÁP] e OZANIMOD [(0.23 MG) + (0.46 MG); CÁP] ao abrigo do Acordo Quadro 2022/173
PT · 10616671
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Unidade Local de Saúde de B...
NIF 515545180
€23,845
2023-12-21
€23,845
2023-12-21
050100242024 - C/ BASE NO CPA 2022_173
PT · 10578309
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Centro Hospitalar e Univers...
NIF 510103448
€124,915
2023-12-20
€124,915
2023-12-20
060101212023-C/ BASE NO CPA 2021_06
PT · 10898667
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar e Univers...
NIF 510103448
€18,900
2023-12-14
€18,900
2023-12-14
Aquisição de Medicamentos do Foro Oncológico e Imunomoduladores SPMS 2021/6
PT · 11250257
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar do Médio ...
NIF 506361608
€63,696
2023-12-13
€63,696
2023-12-13
OZANIMOD 0.23MG (4 CAPS) + 0.46MG (3 CAPS) CAPS (PC.01713.2023)
PT · 10446686
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€571
2023-12-04
€571
2023-12-04
OZANIMOD 0.92MG CAPS
PT · 10405822
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€4,572
2023-11-28
€4,572
2023-11-28
POMALIDOMIDA 1MG CAPS (PC.01529.2023)
PT · 10404776
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€25,850
2023-11-23
€25,850
2023-11-23
PQ/2801/2023 MEDICAMENTOS CPA 6/2021
PT · 10695096
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Instituto Português de Onco...
NIF 506361616
€4,386,556
2023-11-21
€4,386,556
2023-11-21
Aquisição de Medicamento: Luspatercept 75 mg Pó sol inj Fr SC
PT · 10374816
· Ajuste Direto Regime G...
A2 · Late Publication
Hospital do Espírito Santo ...
NIF 508085888
€6,720
2023-11-17
€6,720
2023-11-17
C/ BASE NO CPA 2021_06
PT · 10837183
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Centro Hospitalar e Univers...
NIF 510103448
€5,648,799
2023-11-16
€5,648,799
2023-11-16
NAB-PACLITAXEL 100MG AMP (PC.01376.2023)
PT · 10401828
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€10,800
2023-11-09
€10,800
2023-11-09
Pomalidomida 4 mg Cáps
PT · 10519826
· Ajuste Direto Regime G...
A2 · Late Publication
Instituto Português de Onco...
NIF 506362299
€14,827
2023-11-03
€14,827
2023-11-03
P832-10091475 - PACLITAXEL 5 MG/ ML PO SUSP INJ FR IV (NAB) - CPA 6/2021
PT · 11679672
· Ao abrigo de acordo-qu...
A2 · Late Publication
Unidade Local de Saúde do A...
NIF 508786193
€2,592
2023-10-26
€2,592
2023-10-26
2023009194 - FAR HOSP PL/PP - Paclitaxel
PT · 10320988
· Ajuste Direto Regime G...
A1 · Repeat Direct Award
A2 · Late Publication
ESTADO-MAIOR-GENERAL DAS FO...
NIF 600010180
€3,888
2023-10-19
€3,888
2023-10-19
POMALIDOMIDA 1MG CAPS (PC.00957.2023)
PT · 10362651
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€25,850
2023-10-13
€25,850
2023-10-13
POMALIDOMIDA 3MG CAPS (PC.00906.2023)
PT · 10362480
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€28,853
2023-10-13
€28,853
2023-10-13
Aquisição de diversos medicamentos ao abrigo do acordo de quadro 2022/173
PT · 10316413
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Unidade Local de Saúde de B...
NIF 515545180
€195,159
2023-10-12
€195,159
2023-10-12
CPR 18/2023 Aquisição de Medicamentos do foro oncológico e imunomoduladores (CP2021/6)
PT · 10684926
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Centro Hospitalar Universit...
NIF 506361659
€137,724
2023-10-02
€137,724
2023-10-02
2023007851 - FAR HOSP PL - Paclitaxel 5 mg/ml Pó susp inj Fr IV (nab-Pacl
PT · 10272536
· Ajuste Direto Regime G...
A1 · Repeat Direct Award
A2 · Late Publication
ESTADO-MAIOR-GENERAL DAS FO...
NIF 600010180
€1,080
2023-09-19
€1,080
2023-09-19
T5- 10026940- TALIDOMIDA 50 MG CAPS - CPA 6/2021
PT · 11663757
· Ao abrigo de acordo-qu...
A2 · Late Publication
Unidade Local de Saúde do A...
NIF 508786193
€1,605
2023-09-18
€1,605
2023-09-18
P832- 10091475 - PACLITAXEL 5 MG/ML PO SUSP IN FR IV (NAB) - CPA 6/2021
PT · 11655573
· Ao abrigo de acordo-qu...
A2 · Late Publication
Unidade Local de Saúde do A...
NIF 508786193
€1,080
2023-09-04
€1,080
2023-09-04
Q1/2214/2023 MEDICAMENTOS DO FORO ONCOLÓGICO E IMUNOMODULADORES
PT · 10359208
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Centro Hospitalar de Leiria...
NIF 509822932
€5,875,670
2023-08-30
€5,875,670
2023-08-30
OZANIMOD
PT · 10251319
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar de Setúba...
NIF 507606787
€14,287
2023-08-22
€14,287
2023-08-22
110017/23 - Med. Consumo Geral Farmácia
PT · 10538701
· Concurso público
A2 · Late Publication
A9 · Abnormal Price Reduction
Hospital do Espírito Santo ...
NIF 508085888
€447,741
2023-08-21
€447,741
2023-08-21
Pomalidomida 1 mg Cáps
PT · 10285882
· Ajuste Direto Regime G...
A2 · Late Publication
Instituto Português de Onco...
NIF 506362299
€6,462
2023-08-04
€6,462
2023-08-04
Medicamento Ozanimod Comp ao abrigo do CPA 2022/173 dos SPMS
PT · 10349926
· Ao abrigo de acordo-qu...
A5 · Threshold Splitting
A2 · Late Publication
Unidade Local de Saúde de S...
NIF 517392259
€142,876
2023-08-03
€142,876
2023-08-03
OZANIMOD'S
PT · 10194472
· Ao abrigo de acordo-qu...
A2 · Late Publication
Hospital Garcia de Orta, EPE
NIF 506361470
€2,571
2023-08-02
€2,571
2023-08-02
NAB-PACLITAXEL 100MG AMP
PT · 10354465
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€8,640
2023-07-26
€8,640
2023-07-26
4180241/2023-OZANIMOD 0,92MG CAPS E 0.23MG+0.46 MG
PT · 10568636
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Barreiro ...
NIF 509186998
€0
2023-07-13
€0
2023-07-13
Aquisição de Medicamentos Diversos ao abrigo do CPA 2022/173
PT · 10147237
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Centro Hospitalar Universit...
NIF 509821197
€605,499
2023-07-07
€605,499
2023-07-07
OZANIMOD 0.92MG CAPS
PT · 10326455
· Ao abrigo de acordo-qu...
A2 · Late Publication
Centro Hospitalar Tondela-V...
NIF 509822940
€6,858
2023-07-05
€6,858
2023-07-05
PQ/1860/2023 POMALIDOMIDA 4MG CP
PT · 10106495
· Ao abrigo de acordo-qu...
A2 · Late Publication
Instituto Português de Onco...
NIF 506361616
€399,626
2023-06-15
€399,626
2023-06-15
Pomalidomida 4 mg Cáps
PT · 10226574
· Ajuste Direto Regime G...
A2 · Late Publication
Instituto Português de Onco...
NIF 506362299
€14,827
2023-06-09
€14,827
2023-06-09
Paclitaxel 5 mg
PT · 10237983
· Ajuste Direto Regime G...
A5 · Threshold Splitting
A2 · Late Publication
Unidade Local de Saúde de L...
NIF 516726862
€19,440
2023-06-07
€19,440
2023-06-07
Convite ao abrigo do(s) acordo(s)-quadro 2021/6, 2021/61 e 2022/55 para suprir necessidades na área da saúde
PT · 10102996
· Ao abrigo de acordo-qu...
A2 · Late Publication
A9 · Abnormal Price Reduction
Instituto Português de Onco...
NIF 506362299
€37,016,463
2023-06-06
€37,016,463
2023-06-06
Overview
Total Value Won
€2,048,716,181
Contracts Won
1,854
Score 66500 · CRITICAL RISK
- NIF
- 507791690
- Country
- PT
Directors & Officers
Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.
-
A.V. [P-6d82]Gerentesince 2009-04-20
-
D.W. [P-785e]Gerentesince 2017-12-21
-
F.M. [P-edad]Gerentesince 2021-12-20
-
B.M. [P-6c8e]Sóciosince 2023-11-10
-
C.I. [P-69e7]Sóciosince 2006-07-27
-
A.B. [P-2f08]Gerenteuntil 2011-05-18
-
A.B. [P-33a7]Gerente2012-07-09 → 2014-12-09
-
A.A. [P-f70b]Gerente2015-04-28 → 2018-05-30
-
A.V. [P-6d82]Gerenteuntil 2012-07-09
-
C.G. [P-7e48]Gerente2021-02-17 → 2021-08-05
-
D.A. [P-269a]Gerente2012-07-09 → 2013-04-24
-
J.P. [P-11ab]Gerente2012-07-09 → 2018-11-16
-
J.M. [P-69e4]Gerenteuntil 2012-11-21
-
J.F. [P-5e84]Gerente2021-02-17 → 2022-06-28
-
J.O. [P-fe55]Gerenteuntil 2018-11-16
-
K.R. [P-1f67]Gerente2019-12-03 → 2021-02-17
-
M.F. [P-1a8a]Gerente2013-02-04 → 2015-04-28
-
N.S. [P-2979]Gerente2013-10-28 → 2020-07-08
-
P.E. [P-f30f]Gerente2018-11-16 → 2019-12-03
-
P.V. [P-b91b]Gerenteuntil 2012-07-09
-
R.J. [P-41e8]Gerente2019-12-03 → 2023-09-19
-
S.M. [P-d999]Gerenteuntil 2012-07-09
-
T.T. [P-d21c]Gerente2014-12-09 → 2020-07-08
Ownership & Registries
Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.
Registo Comercial (MJ)
↗
RCBE — Beneficial Ownership Register
↗
Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).
Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned